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Abstract
Background
Fine tuning of the Wnt/β-catenin signaling pathway is essential for the proper development
and function of the liver. Aberrant activation of this pathway is observed in 20%-40% of
hepatocellular carcinomas (HCC). Notum encodes a secreted Wnt deacylase that inhibits
Wnt activity and thereby restricts the zone of activation of Wnt/β-catenin signaling. An
important role of NOTUM has been described in development in drosophila, planaria and
zebrafish, but its role in the mammalian liver is unknown. Notum is required for spatial con-
trol of the Wnt/β-catenin signaling in several animal models and the Wnt/β-catenin pathway
contributes to liver patterning involved in metabolic zonation. Therefore, Notummay be
involved in the liver patterning induced by the Wnt/β-catenin signaling during the adult
stage.
Methodology/principal findings
We generated a conditional Notum knockout mouse mutant to study the effect of the dele-
tion of Notum in the liver. We show that Notum is a direct target of the Wnt/β-catenin signal-
ing in the liver. Liver-specific deletion of Notum did not modify liver zonation, but Notum
deletion had a long-term effect on mouse physiology. In particular, male mutant mice devel-
oped metabolic disorders.
Conclusion
We show that Notum is not a key actor of Wnt/β-catenin-dependent liver patterning of adult
mice, but has role in liver glucose homeostasis. Male mice deficient in Notum specifically in
the liver develop metabolic dysfunctions implicating Notum in the development of Type 2
diabetes.
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Introduction
The morphogenic Wnt/β-catenin signaling pathway is essential in numerous physiological
processes during embryonic development and in the maintenance of self-renewing tissues in
adulthood [1]. It is a key element of liver biology during hepatic development and regulates
metabolic liver zonation in adults [2]. Liver zonation is the specialization of hepatocytes in par-
ticular metabolic functions depending on their position within the liver lobule [3]. The demon-
stration that Wnt/β-catenin signaling governs metabolic zonation by controlling liver
patterning in the adult stage was an important breakthrough [4]. β-catenin signaling controls
perivenous and periportal programs of hepatocytes in an opposite fashion. Using genetically
modified mice with targeted activation or inactivation of β-catenin signaling we identified the
genetic program controlled by β-catenin that regulates liver zonation; we proposed a model of
how β-catenin transcriptionally controls the complex regulatory network that shapes zonated
gene expression in the liver [5]. However, the precise molecular mechanisms by which β-cate-
nin may pattern the liver are still unknown.
Although Wnt/β-catenin signaling is essential for development and adult tissue homeosta-
sis, its constitutive activation is oncogenic in numerous tissues [1]. Activating mutations of
CTNNB1, the gene encoding β-catenin, are present in 20–40% of hepatocellular carcinomas
(HCC), the most frequent primary liver cancer [6], and are the most common oncogenic driver
in HCC [7]. In addition, HCC with CTNNB1mutations define a particular HCC subtype with
well-differentiated histology and better survival than other subtypes [7,8].
Notum was first identified in drosophila as a negative regulator of the Wnt/β-catenin path-
way, involved in tissue patterning during embryonic development. It is required for the normal
development of the wing imaginal disc [9, 10]. In planarian model, Notum is required for the
polarization of the antero-posterior axis during head regeneration and in zebrafish for the cor-
rect development of the neural tube and primary motor innervation [11–13]. In all these mod-
els, Notum acts through the restriction of Wnt/β-catenin signaling activation in a particular
zone, which is necessary for appropriate development or during regeneration after injury.
Notum encodes a hydrolase and it was suggested initially that it cleaves the GPI anchors in two
proteins (Dally and Dally-like protein) that modulate the extracellular distribution of Wnt
activity [9]. However, very recent study shows that Notum is a Wnt deacylase that acts extracel-
lularly, and removes the palmitoleoylation group fromWnt3a protein thereby rendering the
Wnt protein inactive [14, 15].
Notum is required for the spatial control of Wnt/β-catenin signaling in several animal mod-
els and Wnt/β-catenin is central to adult liver physiology especially for metabolic zonation;
consequently, Notummay be involved in the mechanism by which Wnt/β-catenin signaling
patterns the liver in the adult stage. To test this possibility, we generated a conditional Notum
knockout mutant in mice to study the effect of Notum deletion specifically in the liver. We
found that liver-specific deletion of Notum did not modify liver zonation, but had a long-term
effect on mouse physiology; in particular, male mice with liver-specific deletion of Notum
developed metabolic disorders with age.
Materials and Methods
Ethics Statement
Human samples. The serie of surgically resected primary liver tumours (Cochin Hospital,
Paris, France) was already described [8]. All patients provided written informed consent, and
the study was approved by the local ethics comitte (Scientific Comitte of Tumor Bank of
NotumConditional Mouse Model
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Cochin Hospital) according to good clinical practice and applicable laws, and the declaration
of Helsinki.
Animals. Mice were maintained in a 12-h light/dark cycle with ad libitum water and regu-
lar diet (65% carbohydrate, 11% fat, and 24% protein). All animal procedures reported herein
were approved by the Paris-Descartes Ethical Committee for Animal Experimentation under
protocol no. CEEA34.CP.077.12.
Material and Reagents
Anti-6HisTag antibody was purchased from Life Technologies (Carlsbad, CA). Anti-β-actin
was from Sigma-Aldrich (St-Louis, MO). Monoclonal mouse primary antibody against mouse
glutamine synthetase was from BD Transduction Laboratories (le pont de Claix, France) and
anti-Ki67 was from Leica Biosystems (Nanterre, France). The blood glucose monitor and asso-
ciated test strips for glucose measurement were from Accu-Check Active, Roche Diagnostics
(Basel, Switzerland). Recombinant humanWnt3a was obtained from R&D Systems (Minneap-
olis, MN).
Plasmid Constructions
Sequences encoding a 3 glycine-linker and a 6 histidine-tag were added to that encoding the C-
terminal part of Homo sapiens Notum using Notum cDNA (BC060882.1, kindly provided by
Dr. M. Zebisch, University of Oxford, UK) as template and the following primers for PCR
amplification: 5’-ATG GGC CGA GGG GTG CGC-3’ and 5’-CTA GTG GTG ATG GTG ATG
ATG TCC GCC TCC GCT TCC GTT GCT CAG CAT CCC CA-3’ as forward and reverse primers,
respectively. The endogenous stop codon is replaced by a serine codon (underlined), the nucle-
otides in italics code for a 3 glycine-linker followed by a 6 Histidine-tag, and the new stop
codon is indicated in bold. The resulting cDNA fragment, Homo sapiens Notum_3Gly_6His,
was inserted into pDS_EF1-XB (kind gift from Dr. M. Lambert from Institut Cochin, Paris) by
using Gateway1 technologies (Life Technologies) for mammalian expression to generate
pET_HsNotum6HisWT. The corresponding mutant, pET_HsNotum6HisS231A, was obtained
by site-directed mutagenesis with the QuikChange II Kit (Stratagene, La Jolla, CA, USA) and
the primer 5’-TGC TGG CCG GGG CCA GCG CGG GGG-3’ and its reverse complement. All
plasmid sequences were confirmed by DNA sequencing.
Cell Culture and Transfections
The hepatocellular carcinoma cell line HuH7 was cultivated in Dubelcco’s modified Eagle’s
medium (DMEM, Life Technologies) supplemented with 10% fetal bovine serum and 100U/ml
penicillin/streptomycin at 37°C under 5% CO2. For transfection, 0.05x10
6 cells were seeded in
each well of a 24-well plate. Twenty four hours later, plasmids were added and the cells trans-
fected by the Lipofectamine 2000 method according to the manufacturer’s protocol (Life Tech-
nologies). The knockdown of NOTUM was performed with a pool of four different siRNAs
according to the manufacturer’s protocol (SMARTpool accell NOTUM siRNA Dharmacon,
Lafayette, CO).
Luciferase reporter assay
The TOPflash/FOPflash reporter plasmids (Millipore, Billerica, MA) were used to determine
β-catenin-induced Tcf/Lef transcriptional activity. HuH7 cells were co-transfected in triplicate
in accordance with the manufacturer’s instructions with the reporter plasmid and pRL-TK to
NotumConditional Mouse Model
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normalize transfection efficiency. Forty-eight hours after transfection, Luciferase activity was
measured with the Dual-Luciferase reporter assay system (Promega, Madison, WI).
Mouse Models
The Notum targeting construct was generated from PCR products amplified from the DNA of
129/SV ES cells by Pfx polymerase (Life Technologies). A targeting vector was constructed:
LoxP sites were introduced upstream from Notum exon2 and downstream from Notum exon8,
and a hygromycin cassette flanked by FRT sites was introduced as a selection marker down-
stream from Notum exon8. The targeting construct was introduced by electroporation into
embryonic stem cells from mouse strain 129/SV and selected on plates containing hygromycin.
Appropriate clones were identified by PCR and confirmed by Southern blot analysis using 5’
and 3’ probes. Stem cells carrying the construct were injected into blastocysts from C57BL/6J
mice to obtain chimeric mice. After germline transmission, mice carrying the targeted Notum
allele were crossed with mice producing Flp recombinase to remove the hygromycin cassette
resulting in mice carrying a Floxed Notum allele; these mice were then mated with C57BL/6J
mice which express Cre recombinase under the control of the albumin gene promoter with α–
fetoprotein enhancer (Alfp-Cre), which allows Cre recombinase expression at E9.5 specifically
in hepatocytes [16]. For littermate genotyping, tail genomic DNA and primers P1 = (5’-TCT
GAT CCT AGG CCA ACT CG-3’), P2 = (5’-GGT CCC AGA GCG TTG CCA GC-3’) and P3 =
(5’-CCG GCT GTC CGG TGA GAT GC-3’) were used to verify the excision of DNA fragment
which was in between the loxP sites. Generation of the tamoxifen-inducible model of acute β-
catenin activation in the liver (APCΔex14ex14) is described in [4].
Liver Samples and Histological Analysis
Mice were killed by cervical dislocation; some liver samples were snap-frozen in liquid nitrogen
and stored at -80°C until analysis, and others fixed in neutral formalin buffer for 12h and then
embedded in paraffin. Three-micron-thick sections were cut and stained in hematoxylin-eosin.
RNA in situ hybridization was performed on cryostat sections (12 μm thick) as described in [4]
with digoxygenin-labeled riboprobes and counterstaining in Nuclear Fast Red Solution
(Sigma-Aldrich). The sections were counted with VectaMount and photographed with a color
digital camera in a Zeiss photomicroscope. Immunostaining for glutamine synthetase (GS) and
Ki67 antigen were performed as described in [17].
Quantitative RT-PCR
Total RNA was isolated using TRIzol1 reagent according to the manufacturer’s instructions
(Life Technologies). Reverse transcription was performed with 1 μg of total RNA using a Tran-
scriptor First Strand cDNA Synthesis Kit (Roche Diagnostics) and random hexamer as primer.
PCR amplification was performed using Notum Forward 5’-TTT ATG GCG CAA GTC AAG
AG-3’ and Notum Reverse 5’-ACC AGT ACC TGT GCG TGT GT-3’ primers. Primers for
PCR amplification of 18S, Axin2, Lect2, Arg, Glt1 are described in [4]. Real-time quantitative
PCR was performed in triplicate on a LightCycler460 apparatus (Roche Diagnostics) and
results are expressed relative to those for 18S rRNA.
Whole Cell Extraction and Immunoblot Analysis
Cells were washed in ice-cold PBS, lysed in RIPA buffer (Sigma-Aldrich) containing 1X com-
plete protease inhibitor cocktail (Roche Diagnostics) and centrifuged at 13,000 g for 10 min at
4°C. Supernatant (corresponding to the whole cell extract) was kept at -80°C for until analysis.
NotumConditional Mouse Model
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Whole cell extracts were resolved by SDS-PAGE, transferred to nitrocellulose and blocked with
5% BSA. Blots were incubated with primary antibodies overnight at 4°C, washed, incubated
with horseradish peroxidase-conjugated secondary antibodies for 1 h at room temperature,
and washed further. The blots were developed by enhanced chemiluminescence (Pierce, Rock-
ford, IL).
Intra Peritoneal Glucose Tolerance Test
Mice were fasted for 16h and subjected to intraperitoneal glucose loading (2g glucose/kg).
Blood glucose levels were measured at various times over the following 180 min.
Insulin Dosage
Plasma insulin was assayed with a Mouse Ultrasensitive Insulin ELISA kit according to the
manufacturer's guidelines (Alpco, Les Ulis, France)
Statistical analysis
Student’s t test was used to determine the significance of differences between means. A p value
of less than 0.05 was defined as significant and asterisks are used to denote significance as fol-
lows: p<0.05, p<0.01, p<0.001.
Results
NOTUM is overexpressed in human HCC with activating CTNNB1
mutations and is a direct target of the Wnt/β-catenin pathway
We performed microarray studies to identify genes specifically induced in HCC with activating
mutations in CTNNB1. NOTUM was identified as one of the genes most up-regulated in
response to β-catenin activation in HCC (data not shown). We assayed NOTUMmRNA by
quantitative RT-PCR in a cohort of human HCC characterized for CTNNB1mutations [8].
NOTUMmRNA was 6.4 times more abundant in tumor than adjacent non-tumor tissue in
HCC with mutant α-catenin; NOTUMmRNA did not differ in adjacent non-tumor tissue of
HCC whatever of the CTNNB1mutation status of the tumor (Fig 1A). We performed in situ
hybridization to analyze NOTUM expression at the cellular level: NOTUM was strongly over-
expressed in tumoral hepatocytes (Fig 1B).
These findings suggest that β-catenin positively regulates NOTUM expression. To test this
possibility, we studied Notum expression in the liver of mice with acute activation of the β-cate-
nin signaling due to the inactivation of the negative regulator, the Adenomatous polyposis coli
(Apc) gene in hepatocytes (Fig 1C)[4]. In this mouse model, Notum expression in liver of Apc
mutant mice was five-fold higher than that in controls (Fig 1D). We recently identified two
major binding sites for both β-catenin and TCF4, the nuclear partner of β-catenin, in our ChIP
seq analysis that provided the repertoire of the nuclear binding response elements of β-catenin
in hepatocytes [5]. One is in the promoter of the mouse Notum gene, in a region conserved
between mouse and human [18]. The second β-catenin/TCF4 site is around 30 kbp upstream
from the Notum transcription start site (Fig 1E). These observations indicate that Notum is
likely a direct positive target gene of β-catenin in the mouse liver.
The expression pattern of Notum was then analyzed by quantitative RT-PCR in several
adult mouse tissues (Fig 2A). Notum was mostly expressed in the liver and in the lung, with lit-
tle expression in the brain, intestine or kidney. In situ hybridization showed that Notum
expression was restricted to the perivenous region of the liver lobule, as expected for a liver β-
catenin-positive target gene (Fig 2B).
NotumConditional Mouse Model
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Fig 1. Notum is a positive target of β-catenin. (A) Total RNA was extracted from 96 samples (29 from HCC specimens with WT CTNNB1, 38 from HCC
specimens with mutantCTNNB1 and 29 from adjacent non tumor tissue that included 19CTNNB1-mutated HCC and 10 non-mutated HCC). NotummRNA
was assayed by quantitative RT-PCR. (B)NOTUM in situ hybridization with mutantβ-catenin HCC specimens showed significantly strongerNOTUM labeling
in tumor tissue than normal tissue. Seven HCC biopsies were analyzed and a representative result is shown. (C) Tamoxifen-inducible model of acute β-
catenin activation in the liver. (D) Eight week-old mice were intraperitoneally injected with 0.3 mg tamoxifen and total RNA was extracted fromWT liver (black
NotumConditional Mouse Model
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Control of β-catenin transactivation in HuH7 HCC cell line by NOTUM
The Notum gene is conserved across the animal kingdom, and is a negative regulator of Wnt/
β-catenin signaling in several animal models [9, 10, 11,12]. To investigate the ability of mam-
malian Notum to modulate Wnt signaling in hepatocytes, we inserted human NOTUM into the
mammalian expression vector pET. Transfected human HuH7 cells produced Notum that was
able to inhibit a prototype Wnt responsive TOPFLASH reporter induced with recombinant
Wnt3a protein, and this effect was dose dependent (Fig 3A). Therefore, like its counterparts in
drosophila and in C. elegans, human NOTUM appears as a secreted protein which negatively
regulates Wnt/β-catenin signaling. We then analyzed the effect of NOTUM knock-down by
siRNA on β-catenin transactivation in HUH7 cells. Because Notum is a deacylase that removes
rows) and from APCΔex14/Δex14 liver (grey rows) at the indicated times andNotummRNA was assayed by quantitative RT-PCR. Results are normalized to
those for 18S transcripts and the mean ± S.D. of triplicate samples is presented. (E) Genomic environment of theNotum gene (frommRNA-Seq and
ChIP-Seq data described in [5]. Upper blue: mRNA-seq signals. ChIP-Seq signals are shown below with the presence within peaks of WREs depicted first in
red; then in black, ChIP-Seq in Apc-ko conditions with an antibody against Tcf4; in red, ChIP-Seq in Apc-ko conditions with an antibody against β-catenin; in
green, ChIP-Seq in β-catenin-ko conditions with an antibody against Tcf4. Below in yellow, ENCODE data for DNase 1 HS performed with 8-week-old and in
E14.5 embryonic mouse livers (DNaseI Hypersensitivity by Digital DNaseI from ENCODE/University of Washington), of H3K27Ac marks in 8-week-old and in
E14.5 embryonic livers (Histone Mods by ChIP-seq from ENCODE/LICR).
doi:10.1371/journal.pone.0150997.g001
Fig 2. Pattern ofNotum expression. (A) Total RNA was extracted from various mouse tissues andNotummRNA assayed by quantitative RT-PCR.
Results are normalized to those for 18S transcripts and the means ± S.D. of triplicate samples are presented. (B) Representative picture ofNotum in situ
hybridization with WT, NotumKOLiv or APCΔex14/Δex14 mice liver. Portal spaces (PS) and hepatic centrilobular vein (CV) are indicated.
doi:10.1371/journal.pone.0150997.g002
NotumConditional Mouse Model
PLOS ONE | DOI:10.1371/journal.pone.0150997 March 14, 2016 7 / 14
palmiteoylation group fromWnt3a [14, 15], we tested the effect of NOTUM depletion in
Wnt3a-treated cells. While β-catenin signaling was increased in response to Wnt3a stimula-
tion, we did not observe any significant increase in β-catenin signaling after NOTUM knock-
down by siRNA (Fig 3B). Altogether, our data demonstrate that NOTUM was able to control
β-catenin activation when overexpressed, but the role of endogenous NOTUM in HuH7
remains unclear as its depletion by siRNA did not significantly increase β-catenin transactiva-
tion level.
Generation of a conditional mouse model of Notum inactivation
We investigated the possible role of Notum in the liver patterning involved in metabolic zona-
tion. We produced a conditional mouse model of Notum inactivation to test whether deletion
of Notum in the hepatocytes of adult mice affected metabolic zonation (Fig 4A). We produced
mice carrying Notum alleles in which the sequence from exon 2 to exon 8 is flanked by LoxP
sites. Southern blotting with positive embryonic stem cell clones confirmed that the homolo-
gous recombination of the targeted allele was as intended (Fig 4B). These clones were injected
into blastocyts to obtain chimeric mice. After germline transmission, Notumlox/lox mice were
produced using C57BL/6J mice expressing FLP recombinase to remove the hygromycin selec-
tion cassette and mated with C57BL/6J until backcross N3. Notumlox/lox mice were then mated
with Alfp-Cre mice, allowing Cre recombinase expression in hepatoblasts, from embryonic
stage E10.5 [16]. PCR of liver genomic DNA with various primers confirmed that the sequence
between Notum exon 2 and exon 8 had been deleted in the liver of Notumlox/lox Alfp-Cre mice;
these mice were named NotumKOLiv (Fig 4C). Invalidation of Notum expression was con-
firmed at the mRNA level by RT-qPCR with samples from E16.5 embryo livers of NotumKOLiv
(Fig 4D) and by in situ hybridization. No NotummRNA was found in liver sections from adult
NotumKOLiv mice whereas NotummRNA was detected across the whole lobule in the liver of
mice with constitutive β-catenin signaling in hepatocytes (Apcmutant mice) (Fig 2B).
These various findings confirm the deletion of Notum from the liver of NotumKOLiv mice.
Fig 3. Regulation of Wnt3a/β-catenin signaling byNOTUM in HCC cell line Huh7.Huh7 cells were transfected with empty vector and pET-Notum6His as
indicated, together with 50ng of TopFLASH Firefly Luciferase plasmid and 5ng of control Renillia Luciferase. Twenty-four hours after transfection, cells were
stimulated or not with 50ng/ml recombinant humanWnt3a and analyzed for luciferase activity 24 hours later. Data represent means of three independent
transfections with the standard deviations indicated. NOTUM silencing did not increase β-catenin activity. HuH7 cells were reverse-transfected as indicated
with 100 pmol ofNOTUM siRNA. Twenty four hours after, β-catenin luciferase reporters (TOPflash/FOPflash) were transfected andWnt3a was added as
indicated 16 hours post-transfection of the plasmids encoding luciferase. Luciferase activity was measured the following day.
doi:10.1371/journal.pone.0150997.g003
NotumConditional Mouse Model
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Deletion of Notum in the liver did not affect liver architecture or liver
zonation
NotumKOLiv mice were born in Mendelian proportion and did not display any macroscopic
phenotype until adult. Liver weight and liver to body ratio were similar to those for wild-type
mice. H&E staining and proliferation studies of liver sections did not show any major defect in
NotumKOLiv mice (data not shown). We analyzed liver zonation in the hepatocyte-specific
Fig 4. Generation and validation of conditional mousemodel ofNotum inactivation. (A) Diagram of the generation of theNotum conditional knockout.
Structure of Notum locus with the targeted allele is shown. Numbered boxes indicate exons. Exons 2 to 8 were flanked by loxP sites (black arrowheads). A
hygromycin-resistance cassette flanked by FRT sites was inserted downstream from the 3’ loxP site. The hygromycin-resistance cassette was excised by the
expression of the FLP recombinase in vivo. Liver-specific disruption of exons 2 to 8 flanked by loxP sites was achieved by crossingNotumWT/loxmice with
Alfp-Cre mice. (B) Genomic DNA from NotumWT/WT or NotumWT/loxmice was digested with BglII/HindIII or EcoRI /HindIII and was analyzed by Southern blot
using probe1 or probe2, respectively. (C) Genotyping by PCR of liver DNA from: control (NotumWT/WT), NotumWT/ΔNot, andNotumKOLiv (NotumΔNot/ΔNot)
mice, with the P1, P2 and P3 primers shown in A. (D) Total RNA was extracted from liver ofNotumWT/WT (control) andNotumKOLiv E16.5 embryos and
assayed by quantitative RT-PCR for NotummRNA.
doi:10.1371/journal.pone.0150997.g004
NotumConditional Mouse Model
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Notum knockout mice by in situ hybridization: in the mutant mice, expression of the β-catenin
positive targets Glutamine synthetase, Axin2 and Lect2 were restricted to pericentrilobular
hepatocytes whereas expression of the negative targets Gls2 and Arg were restricted to peripor-
tal hepatocytes; this pattern is not different from that in the controls (WT liver) indicating no
modification of liver zonation (Fig 5A and 5E). This was confirmed by analysis of the abun-
dance of the mRNAs by RT-qPCR, which provided no evidence of difference between the
mutant and the control animals (Fig 5F and 5G).
Deletion of Notum in the liver significantly increases the risk of obesity
with age
The published evidence suggests that Notummay be involved in fine tuning regulation of Wnt/
β-catenin signaling rather than “on/off” regulation. Consequently, we tested for the effects of
Notum depletion in the liver later during the lives of the mice. We analyzed the phenotype of
NotumKOLiv mice at 4, 6, 9 and 12 months of age. We have noticed no difference in the liver
histology between old WT and KOmice. In addition, the metabolic zonation and Wnt/β-cate-
nin signaling in NotumKOLiv mice at these different ages were indistinguishable from those in
the wild-type (data not shown). However, numerous NotumKOLiv males displayed significant
weight gain from 6 months of age, such that the mean weight of the males was 38.6 g at 12
months (versus 27.9 g for their WT littermates, Fig 6A). The liver to body ratio was unaffected
(3.48±0.12% for the WT versus 3.70±0.15% for NotumKOLiv), but there was substantial excess
of pelvic fat in 12 month-old NotumKOLiv mice (Fig 6B), and the fasting blood glucose concen-
tration was significantly elevated (108.9±6.1 mg/dl for one year old NotumKOLiv vs 84.2±4.1
mg/dl in WT littermates; Fig 6C). NotumKOLiv mice were glucose intolerant, and had very
high plasma insulin concentrations after 16h of fasting (0.89 ± 0.12 ng/ml versus 0.15 ± 0.02
ng/ml for their WT littermates) (Fig 6D and 6E). Intriguingly, NotumKOLiv females displayed
unchanged body weight, pelvic fat and fasting blood glucose concentration when compared to
WT female littermates (data not shown). Thus, our results indicate a sexual dimorphism in
NotumKOLiv mice with metabolic disorders that appeared specifically in males with age.
Discussion
In this study, we show that NOTUM expression is strongly up-regulated in human HCC, spe-
cifically in the subclass of HCC carrying an activating mutation of CTNNB1. This is consistent
with the report by Torisu et al. [18]. We used the conditional ApcΔ14 mouse model of acute acti-
vation of β-catenin signaling in the liver to confirm that Notum was positively regulated by β-
catenin in that organ. In situ hybridization of WT liver sections showed that Notum expression
is restricted to pericentrilobular hepatocytes, which is the zone where β-catenin signaling is
active in the physiological liver [4]. However, Notum expression extended to the whole lobule
in Apc-deficient liver. ChIP seq experiments identified two TCF4-binding sites in the Notum
regulatory region. Our findings are thus consistent with Notum being a direct target of β-cate-
nin in mouse liver.
We confirmed that NOTUM can inhibit Wnt/β-catenin signaling in vitro with the overex-
pression of recombinant NOTUM in a Wnt3a-stimulated hepatocyte cell line, HuH7. But in
vitro knock-down of Notum in Wnt-3a-treated HuH7 cells failed to increase β-catenin activity
showing that the control of the β-catenin signaling is more complex than anticipated. Accord-
ingly, analyses with the Notum conditional mouse model we generated did not reveal any mod-
ification of liver zonation in vivo in the mutant animals. Even though Notum expression was
completely abolished in hepatocytes, at least from E16.5, liver development was unaffected in
mutant mice and they did not display any phenotype until adults. We cannot rule out the
NotumConditional Mouse Model
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Fig 5. Notum inactivation did not modify liver metabolic zonation. (A-B-C-D-E) Glutamine synthetase
immunostaining, and Axin2 and Lect2 Gls2 and Arg in situ hybridization were performed on NotumWT/WT and
NotumKOLiv liver samples. Representative pictures are shown. Portal spaces (PS) and hepatic centrilobular
vein (CV) are indicated. (F-G) Quantitative RT-PCR analysis of Axin2, Lect2, Arg and Glt1 mRNAs in
NotumWT/WT (n = 4, black rows) and liver NotumKOLiv (n = 5, grey rows); values were normalized to those for
18S transcripts level, and means ± S.E.M are reported.
doi:10.1371/journal.pone.0150997.g005
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Fig 6. Notum depletion in the liver increases risk of age-related obesity in males. (A) Male NotumWT/WT (n = 8, plain line) andNotumKOLiv (n = 5, dashed
line) mice were weighed at various adult ages. Body weight is presented as means ± S.E.M. (B) Pelvic fat pads were harvested from 1 year-oldNotumWT/WT
(n = 6) andNotumKOLiv(n = 6) mice and weighed. (C) Blood glycemia was measured in 1 year-oldNotumWT/WT and mice. (D) Intraperitoneal glucose
tolerance tests were performed on 1 year-old NotumWT/WT (n = 6, plain line) andNotumKOLiv (n = 6, dashed line) mice. Experiments were performed in
duplicate and means ±S.E.M. are shown. (E) Plasma insulin concentrations in fasted mice.
doi:10.1371/journal.pone.0150997.g006
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possibility that Notum is involved at earlier stages of liver development, but Notum does not
appear to be required during the late stage of liver development. In addition, liver metabolic
zonation remained unchanged in mutant mice, at least until one year of age. Altogether, our
results argue either that in the liver, NOTUM do not control Wnt/β-catenin signaling or that
complex redundant mechanisms control and maintain Wnt activity.
Finally, we observed a progressive increase in body weight with age associated with a signifi-
cant increase in blood glycemia, glucose intolerance and insulinemia in male Notummutant
mice, relative to control littermates. This suggests that male NotumKOLiv mice are at high risk
of developing metabolic disorders such as diabetes. Although liver from NotumKOLiv did not
display any phenotype, the hepatic loss of secreted NOTUMmay affect peripheral organs that
are also contributors to insulin resistance. Notably, a substantial excess of pelvic fat was
observed in NotumKOLiv. Thus, peripheral tissue (at least adipose tissue) may contribute to the
pathophysiological mechanisms resulting from the hepatic loss of Notum.
Several genome wide association studies indicate that several components of the Wnt signal-
ing pathway including TCF7L2, the nuclear partner of β-catenin, are genetic determinant of
type 2 diabetes (T2D) risk in humans[19] [20]. However, our results questioned the fact that
NOTUM is a component of the Wnt/β-catenin pathway in the liver. Regardless of the potential
link of NOTUM to the Wnt pathway, NOTUM appears as a new susceptibility factor to diabetes
and obesity. It reveals also that it is important to look outside the pancreas to understand the
mechanisms linking genetic variation and T2D risk [21] [22].
Importantly, we observed that the obesity and glucose intolerance developed in NotumKOLiv
mice are gender-specific, the metabolic phenotype was not present in NotumKOLiv old
female. Sexual dimorphism in obesity is well described in humans [23]. While the connection
between obesity and diabetes is well established in men, it is less so for women and the mecha-
nism underlying these sexually dimorphic influences remain poorly understood. Although not
investigated, NOTUMmight be a new factor responsible for sex differences in metabolic
disorders.
In conclusion, we report that Notum is strongly expressed by hepatocytes and is a direct tar-
get of the Wnt/β-catenin signaling in liver. Disruption of its expression in the liver does not
have significant consequences on liver development and metabolic zonation. We also show
that obesity and deregulation of glucose homeostasis appeared progressively with age specifi-
cally in male Notum-deficient mice, implicating NOTUM in the physiopathology of obesity
and T2D in a gender-specific manner.
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